The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1096
A Progestin-Releasing Intrauterine Device For Long-Term Contraception
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A Progestin-Releasing Intrauterine Device For Long-Term Contraception
The FDA had approved an intrauterine contraceptive device that releases the synthetic progestin levonorgestrel over a period of five years. The device has been available in Europe for 10 years.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: A Progestin-Releasing Intrauterine Device For Long-Term Contraception
Article code: 1096c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.